Urea derivatives as a multipurpose scaffold for enzyme inhibitor design

Overview

This offering presents a versatile medicinal chemistry platform built around biaryl urea derivatives. Urea-based scaffolds are widely recognized in biochemistry and medicinal chemistry for their ability to serve as enzyme inhibitors, with kinase inhibitors being a prominent example. The research applies the Topliss operational scheme, a systematic approach for optimizing substituent selection, to cover a broad range of steric, electronic, and lipophilic variations. Because all compounds are derived from the same underlying chemistry, the platform enables coherent structure–activity relationship studies and efficient analog generation for drug discovery programs.

Technical specifications

Key features:

• Biaryl urea scaffold serving as a multipurpose core structure for enzyme inhibitor development
• Topliss scheme–based design principle enabling systematic variation of steric, electronic, and lipophilic residues
• Consistent synthetic chemistry across the compound series, supporting reproducible analog production
• Applicability to kinase inhibition and broader enzyme inhibitor discovery efforts
• Suitable for medicinal chemistry hit-to-lead optimization and structure–activity relationship studies

Technology readiness level

The platform is positioned at an early research stage. The design principle and scaffold concept have been defined, and compound synthesis follows a unified chemistry route. Further validation, including biological screening and structure–activity profiling, is required to advance the platform toward lead candidate status and potential pharmaceutical application.